British medical equipment manufacturing company Smith+Nephew has received the US Food and Drug Administration (FDA) 510(k) approval for its AETOS shoulder system.

Indicated for both anatomic and reverse total shoulder arthroplasty, the system is designed to restore patients’ range-of-motion and help reduce arthritic shoulder pain.

It features the AETOS Meta Stem, which provides metaphyseal fixation with an in-lay collar to enhance stability, preserve bone, and maintain anatomy, said the medical device maker.

The system also features a humeral head, reverse poly liner, glenosphere, and baseplate.

AETOS System design surgeon James Kelly said: “The AETOS Shoulder System was designed to be a cutting-edge press fit, bone conserving, convertible humeral stem.

“The system is designed for surgeons who desire maximum flexibility to reconstruct the humerus and glenoid, using an efficient and intuitive system that helps prioritise patient outcomes.”

Smith+Nephew said that its AETOS Shoulder System is the latest addition to its growing portfolio of Upper Extremity solutions.

Also, it complements the company’s portfolio of Sports Medicine shoulder repair solutions.

The system offers a compact, comprehensive portfolio of solutions for healthcare professionals, enhancing their surgical experience with intraoperative flexibility.

It reduces the number of steps for conversion and instruments required for primary anatomic and reverse, and simplifies the operating room workflow, said the company.

Smith+Nephew global orthopaedics president Brad Cannon said: “Receiving FDA clearance for the AETOS Shoulder System is a major milestone for Smith+Nephew.

“This platform is the culmination of years of research and development and represents our commitment to providing healthcare professionals with the best possible technology for their patients.

“We are confident that this platform will further evolve the standard of care for shoulder surgery and are excited to see the impact it has on patient outcomes.”

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue.

Last month, the company introduced its artificial intelligence (AI)-powered RI.KNEE ROBOTICS v2.0 personalised planning software and RI.Insights data visualisation platform.